Additionally, UCMSCs or UCBMSCs decrease the serum levels of TNF-α and IL-6 and increase the percentage of Treg cells in the peripheral blood, according to the results from in vitro and animal RA models [109]. The gene discussed is IL6; the disease is rheumatoid arthritis.